H31.22

Clinical Causes: Genetic mutations: CACD is often inherited in an autosomal dominant pattern, meaning a mutation in a single gene can cause the disease. Family history: A history of similar eye conditions in relatives increases the risk. Unknown environmental factors: While genetics play a primary role, the exact environmental contributions are not well defined.

Key Symptoms: Gradual central vision loss: Patients typically experience a slow decline in clarity and sharpness of central vision. Difficulty recognizing faces or reading: Central vision deterioration impacts tasks that require detailed vision. Color perception changes: Some individuals notice difficulty distinguishing colors as the condition progresses. Absence of pain or redness: Unlike some other eye disorders, CACD generally does not cause pain or inflammation. Possible metamorphopsia: A visual distortion where straight lines appear wavy or bent in the affected area.

Diagnosis Path: The diagnosis of central areolar choroidal dystrophy involves a comprehensive eye exam including visual acuity testing, fundus examination, and imaging techniques such as optical coherence tomography (OCT) to visualize retinal and choroidal layers. Fluorescein angiography may be employed to evaluate blood flow in the choroid. Family history and genetic testing can support diagnosis, especially in hereditary cases. Regular monitoring helps assess disease progression and guide management strategies.

Treatment Protocols: Currently, there is no cure for CACD. Management focuses on preserving vision and adjusting to changes through supportive care. These include visual aids like magnifiers or specialized glasses. Low vision rehabilitation services can optimize remaining vision for daily activities. In some cases, research into gene therapy or other experimental treatments is ongoing, but such options are not yet widely available. Early detection and regular follow-up are essential to address complications and potentially slow disease progression.